Atlas Trials

Clarity Pharmaceuticals Ltd

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Clarity Pharmaceuticals Ltd

RecordFirmDate
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy (NCT06056830)Clarity Pharmaceuticals Ltd2023-12-21
64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) (NCT05407311)Clarity Pharmaceuticals Ltd2022-09-19
64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) (NCT05249127)Clarity Pharmaceuticals Ltd2022-04-11
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) (NCT04868604)Clarity Pharmaceuticals Ltd2021-08-11
Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (NCT04839367)Clarity Pharmaceuticals Ltd2021-07-13
A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO) (NCT04438304)Clarity Pharmaceuticals Ltd2021-03-02
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma (NCT04023331)Clarity Pharmaceuticals Ltd2020-08-18
Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ (NCT03936426)Clarity Pharmaceuticals Ltd2018-07-09

Track Clarity Pharmaceuticals Ltd automatically

Every clearance here is in the API, with alerts when new ones post.